Peer-reviewedCC BY-NC-NDLa Tunisie medicale
Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques
5 affiliations
- 1Internal medicine department, Bab El Oued University Hospital center, Bab El Oued city, Faculty of Medicine, University of health sciences, Algiers, Algeria
- 2Radiology department, Bab El Oued University Hospital center, Bab El Oued city, Faculty of Medicine, University of health sciences, Algiers, Algeria
- 3Nephrology Department, Mustapha Bacha University Hospital Center, University of health sciences, Algiers, Algeria
- 4Rheumatology department, Benaknoun University Hospital center, Faculté of Medicine, University of health sciences, Algiers, Algeria
- 5Department of Hepato-gastro-enterology, Bab El Oued University Hospital center, Bab El Oued city, Algiers, Algeria
Related
- Early Recognition of Patients with Neuronopathic Forms of Mucopolysaccharidosis Type II in Clinical Practice
- Orthopaedic Manifestations of Mucopolysaccharidosis.
- Induction of Oral Immune Tolerance Enables Sequential AAV9/AAV8 Gene Therapy in Mucopolysaccharidosis IVA
- Synthesis of the Endogenous Non-Reducing End Heparan Sulfate Disaccharides for Newborn Screening and Diagnosis of Mucopolysaccharidosis types I and II
- Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI
BibTeX
@article{daghorabbaci2026moyamoya,
title = {{Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques}},
author = {Karima Daghor-Abbaci and Radhia Ait Chalal and Hind Arzour and Assia Haddouche and Houria Saoula and Nazim Laraba},
journal = {La Tunisie medicale},
year = {2026},
month = jul,
doi = {10.62438/tunismed.v104i07.6678},
url = {https://europepmc.org/article/PMC/PMC13751068},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques
AU - Karima Daghor-Abbaci
AU - Radhia Ait Chalal
AU - Hind Arzour
AU - Assia Haddouche
AU - Houria Saoula
AU - Nazim Laraba
PY - 2026
DA - 2026/07/01
JO - La Tunisie medicale
DO - 10.62438/tunismed.v104i07.6678
UR - https://europepmc.org/article/PMC/PMC13751068
SN - 0041-4131
SN - 2724-7031
ER -